Drug profile · INN
pemigatinib
PEMAZYRE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pemigatinib (PEMAZYRE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN pemigatinib
Brand PEMAZYRE
Route ORAL
Formulation TABLET
ATC code L01EN02
Frequently asked questions
What is pemigatinib?
pemigatinib (PEMAZYRE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pemigatinib?
PEMAZYRE is a marketed brand name for pemigatinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pemigatinib?
pemigatinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.